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Background: Group A Streptococci infections are the cause for Acute Rheumatic Fever and Chronic Heart 
Disease. Therefore it would be ideal to treat every patient presenting with a streptococcal infection with 
antibiotics. For patients presenting with a sore throat the difficultly is to correctly identify those who have 
streptococcal infection and should be prescribed antibiotics.  
Aims: We have evaluated a point of care antigen test for the use in patients presenting with sore throat and 
have correlated the results to the clinician’s impression and the Centor Score.  
Methods: Prospective single centre cohort study for diagnostic accuracy.  
Results: Positive and negative predictive values and etiologic predictive values indicate that the test could be 
used in the Mount Isa Emergency Department to rules in and to rule out patients with a sore throat for 
antibiotic treatment. In any realistic setting the test etiologic predictive values indicated that the test can rule 
out patients for antibiotic treatment.  
Conclusions/Recommendations: A Group A Streptococci point of care test would improve diagnostic accuracy 
for patients presenting with a sore throat.  
